Alembic Pharmaceuticals Limited recalls Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceutica…
- Recall date
- October 10, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0156-2026
- FDA classification
- Class III
- Brand / firm
- Alembic Pharmaceuticals Limited
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30
Get recall alerts
Free email alert whenever Alembic Pharmaceuticals Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alembic Pharmaceuticals Limited